• Enlitic's subsidiary Laitek to migrate over 71 million legacy clinical files for Penn Medicine Doylestown Health
• Project demonstrates validation of Enlitic's data migration and integration capabilities
• Enlitic aims to expand relationship with Penn Medicine by pursuing additional solutions

Enlitic, Inc. (ASX: ENL) has signed a data migration contract valued at US$1.5 million with Penn Medicine Doylestown Health, part of Penn Medicine, University of Pennsylvania Health System, in the USA. Penn Medicine Doylestown Health is a regional healthcare provider in Pennsylvania that became part of the Penn Medicine network in 2025, one of the world's leading academic health systems in the US. Under the agreement, Laitek, Enlitic's 100%-owned medical imaging data migration and integration company, will migrate over 71 million legacy clinical files from the hospital's existing electronic medical record archive environment into a modernised archive structure within Enlitic's platform using a bespoke solution, proprietary to ENL. The project is the second of its kind with Penn Medicine and includes data transformation, indexing, and validation to support continued clinical access to historical records. The initiative demonstrates considerable validation of the Company's service offering and reiterates ENL's position as a long-term, established partner to leading organisations in the US healthcare sector. The project will commence in Q2 2026 and is expected to complete later this calendar year. Enlitic CEO Michael Sistenich said the company intends to pursue the implementation of additional Enlitic solutions with Penn Medicine, aiming to meaningfully expand the relationship with the leading US health system.

Enlitic aims to pursue the implementation of additional solutions with Penn Medicine, utilising this initial contract as an opportunity to meaningfully expand the relationship with the leading US health system.